Simplex Trading’s Bioventus BVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-300
Closed -$2K 8684
2025
Q1
$2K Sell
300
-1,000
-77% -$9.99K ﹤0.01% 7935
2024
Q4
$13K Sell
1,300
-91,500
-99% -$1.08M ﹤0.01% 6987
2024
Q3
$1.11M Buy
92,800
+7,300
+9% +$63.1K ﹤0.01% 2837
2024
Q2
$491K Buy
85,500
+33,400
+64% +$183K ﹤0.01% 3686
2024
Q1
$270K Buy
52,100
+43,200
+485% +$211K ﹤0.01% 4524
2023
Q4
$46K Buy
8,900
+8,400
+1,680% +$33.2K ﹤0.01% 6146
2023
Q3
$1K Buy
+500
New +$1.75K ﹤0.01% 8257
2022
Q1
Sell
-800
Closed -$11K 10427
2021
Q4
$11K Buy
+800
New +$11.4K ﹤0.01% 8923

Other funds holding BVS

Simplex Trading's BVS Position: Q1 2025 in Review

Simplex Trading sold out of Bioventus (BVS) in Q1 2025, closing a stake of 21,180 shares — an estimated $212K sold.

Simplex Trading first reported a position in BVS in Q1 2022 and held it in 11 quarters. The position peaked at $222K in Q4 2024. 144 funds tracked by Wall St. Rank hold BVS as of Q1 2025.

  • Simplex Trading reported no remaining Bioventus position as of Q1 2025 after selling out during the quarter.
  • Simplex Trading sold 21,180 Bioventus shares in Q1 2025, an estimated $212K.
  • Simplex Trading first reported a position in Bioventus in Q1 2022 and held it in 11 quarters.
  • Simplex Trading's Bioventus position peaked at $222K in Q4 2024.
  • 144 funds tracked by Wall St. Rank held Bioventus as of Q1 2025.

Based on Simplex Trading's 13F filing for Q1 2025, filed 12 May 2025.